BeOne Medicines AG (ONC) Stock Price & Analysis
ONC$372.80-0.56 -0.15%
$39.84B
Market Cap
5.04
P/E
56.36
Forward P/E
—
Score
BeOne Medicines AG (ONC) Stock Price & Analysis
ONC price $372.80 -0.56 -0.15%
- Ticker
- ONC
- Price
- $372.80
- Change
- -0.56 -0.15%
- Market cap ?
- $39.84B
- P/E ?
- 5.04
- Forward P/E ?
- 56.36
- Dividend yield ?
- 0.00%
- Beta ?
- 0.52
- Sector
- Healthcare
- Industry
- Biotechnology
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1070000 | 238387000 | 198220000 | 428212000 | 308874000 | 1176283000 | 1415921000 | 2458779000 | 3810241000 | 5343033000 |
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company’s commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK) for the treatment of various blood cancers; TEVIMBRA, an anti-PD-1 antibody immunotherapy for the treatment of various solid…
Insights · Dividends · Forecast · Financials · Learn